Phil Gutry is CHIEF BUSINESS OFFICER of Graphite Bio, Inc.. Currently has a direct ownership of 299,941 shares of GRPH, which is worth approximately $0. The most recent transaction as insider was on Apr 11, 2022, when has been sold 5,000 shares (Common Stock) at a price of $4.01 per share, resulting in proceeds of $20,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 300K
0% 3M change
0% 12M change
Total Value Held $0

Phil Gutry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 11 2022
BUY
Open market or private purchase
$20,050 $4.01 p/Share
5,000 Added 1.64%
299,941 Common Stock
Jun 29 2021
BUY
Conversion of derivative security
-
8,126 Added 2.69%
293,471 Common Stock
Apr 18 2021
BUY
Exercise of conversion of derivative security
$20,670 $6.11 p/Share
3,383 Added 1.17%
285,345 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$27,422 $0.3 p/Share
91,406 Added 24.48%
281,962 Common Stock

Also insider at

AVTX
Avalo Therapeutics, Inc. Healthcare
PG

Phil Gutry

CHIEF BUSINESS OFFICER
Rockville, MD

Track Institutional and Insider Activities on GRPH

Follow Graphite Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRPH shares.

Notify only if

Insider Trading

Get notified when an Graphite Bio, Inc. insider buys or sells GRPH shares.

Notify only if

News

Receive news related to Graphite Bio, Inc.

Track Activities on GRPH